All stories tagged :

Sample Category Title

Asia-Pacific Weight Loss Market Size, Growth Trends and Forecast Report 2025-2033...

admin
Pr Newswire

CLOU’s BESS Tour: Empowering Renewable Latin America

admin
Pr Newswire

Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal...

admin
Pr Newswire

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover...

admin
Pr Newswire

Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results

admin
Pr Newswire

Nexdata at Tech.AD Europe 2025: Hyperspeed Project Scaling with Next-Gen Data...

admin
Pr Newswire

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the...

admin
Pr Newswire

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

admin
Pr Newswire

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results...

admin
Pr Newswire

GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and...

admin
Pr Newswire

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...